Skip to content
StockMarketAgent
Direct answer
WELL trades against a final fair-value range of $56.34-$78.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $56.3, high $78.6, with mid-point at $65.8.
Stock analysis

WELL Welltower Inc. fair value $66–$79

WELL
By StockMarketAgent.AI team· supervised by
Analizado: 2026-05-09Próxima actualización: 2026-08-09Methodology v2.4Archetype: REITNYSE · Real Estate
View archive
Precio
$214.63
▼ -148.84 (-69.35%)
Valor razonable
$66
$66–$79
Calificación
Vender
confidence 88/100
Potencial alcista
-69.3%
upside to fair value
Margen de seguridad
$55.92
buy below · 15%
Capitalización bursátil
$151.5B
P/E fwd 64.5
Respaldo en inglésES
Mostrando la fuente en inglés mientras traducimos
Este informe aún no se ha traducido. Actualice en unos minutos una vez que la cola de traducción se ponga al día.

§1 Resumen ejecutivo

  • Composite fair value $66 with high case $79.
  • Implied downside of 69.3% to fair value.
  • Moat 6.5/10 · confidence 88/100 · REIT.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$66
Margin of safety
-226.2%
Confidence
88/100
Moat
6.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$214.63Price
FV $65.79
High $78.60

WELL trades against a final fair-value range of $56.34-$78.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Unmatched real estate portfolio in
    Unmatched real estate portfolio in highly attractive, high-barrier micro-markets.
  • Data Science platform enabling highly
    Data Science platform enabling highly disciplined capital allocation.
  • Cycle upside
    Unprecedented demand driven by the aging 'silver tsunami' outstripping new senior housing supply.

§2 Caso bajista

A sustained high-interest-rate environment coupled with sticky healthcare labor inflation would severely constrain accretive acquisitions while crushing property-level operating margins, driving valuation sharply toward the $56.34 low.

Cómo puede fallar esta tesis

Cost of Capital Blowout

· Medium

Prolonged high interest rates severely limit accretive acquisition volume and compress real estate cap rates across the sector.

FV impact
Severe downside to $56.34
Trigger
12-24 months

Structural Labor Squeeze

· Medium

Persistent shortages in healthcare staffing drive runaway wage inflation, permanently squeezing operator margins and reducing AFFO generation.

FV impact
Moderate downside
Trigger
24-36 months

Demographic Supply Glut

· Low

Competitors massively overbuild in key micro-markets ahead of the aging wave, crushing occupancy and pricing power.

FV impact
Minor downside
Trigger
3-5 years
Señales de alerta temprana a vigilar
MétricaActualUmbral de activación
Decelerating or negative sequential AFFO per share growth.MonitorDeterioration versus the report thesis
Stalling occupancy rate recovery across the core premium senior housing portfolio.MonitorDeterioration versus the report thesis
Narrowing investment spreads between implied cap rates and marginal cost of debt.MonitorDeterioration versus the report thesis
Surging operator labor costs per occupied unit compressing site-level EBITDAR.MonitorDeterioration versus the report thesis
Multiple expansion on recently closed asset sales indicating market exhaustion.MonitorDeterioration versus the report thesis

§3 Historial financiero

Cuenta de resultados — últimos seis períodos
ConceptoT−0T−1T−2T−3CAGR
Período2022-12-312023-12-312024-12-312025-12-31Trend
Ingresos$5.78B$6.48B$7.85B$10.67B+22.7%
Beneficio bruto$2.22B$2.53B$3.02B$4.18B+23.5%
Beneficio operativo$746.2M$940.5M$1.15B$355.2M-21.9%
Beneficio neto$141.2M$340.1M$951.7M$936.8M+87.9%
BPA (diluido)$0.30$0.66$1.57$1.39+66.7%
EBITDA$2.04B$2.40B$2.78B$2.31B+4.2%
I+D
SG&A$150.4M$179.1M$235.5M$1.75B+126.5%

Puntuaciones de calidad

Piotroski F-score
7 / 9
Compuesto de calidad 0–9
Altman Z-score
3.89
Riesgo de quiebra (>3 seguro)
Beneish M-score
-3.02
Riesgo de manipulación de beneficios
OCF / Beneficio neto
3.08×
>1 indica alta calidad de los beneficios
Umbral de calidad contable
Pass
Umbral ajustado por sector
ROIC
0.2%
Rentabilidad del capital invertido
Sección 3

Numbers analysis

Asignación de capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Suscriptores individuales — desde §411 secciones más

Leer el análisis completo — 11 secciones más.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Informe completo para cada ticker cubierto
24 meses de archivo de calificaciones
Briefings de lista de seguimiento + alertas de cambio de calificación
Exportación PDF + DOCX en cualquier idioma
Comenzar prueba gratuita
Cancela cuando quieras.
FAQ

WELL — frequently asked questions

  1. Based on our latest analysis, WELL looks meaningfully overvalued. The current price is $215 versus a composite fair-value midpoint of $65.8 (range $56.3–$78.6), which implies roughly 69.3% downside to the midpoint.
Related coverage

Names readers of WELL also follow

Same archetype: reit